Travel Vaccines Market Report 2023, Industry Size, Share, Demand, Trends and Forecast till 2028

IMARC Group has recently released a new research study titled “Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

How big is the travel vaccines market?

The global travel vaccines market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 56.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.95% during 2023-2028.

What are travel vaccines?

Travel vaccines, also known as travel immunizations, are vaccinations that travelers may need to get before visiting certain areas where there is a high risk of specific infectious diseases. These vaccines provide immunity against diseases that are either rare or not present in the traveler's home country but are prevalent in the destination region. Examples include Yellow Fever, Hepatitis A and B, Typhoid, and Rabies vaccines. Obtaining the proper vaccinations is an essential part of pre-travel healthcare preparation. It not only protects the individual traveler but also helps to prevent the spread of diseases across borders.

Request to Get the Sample Report: https://www.imarcgroup.com/travel-vaccines-market/requestsample

Travel Vaccines Market Trends and Growth Drivers:

The rise in international travel represents one of the key factors driving the growth of the market across the globe. As people increasingly travel for tourism, business, and education, the demand for immunizations against various region-specific diseases rises. This trend is particularly evident among corporate travelers and students who are often required to get vaccinated before traveling to certain countries.

Companies with international operations often mandate vaccinations for their employees who need to travel frequently, which is boosting the demand for travel vaccines. In addition to this, the international adoption of travel regulations that necessitate vaccinations, like the Yellow Fever vaccine for travel to certain African and South American countries, also contributes to the market growth.

Technological advancements in vaccine development are also contributing to the market expansion. Newer vaccines with higher efficacy rates and fewer side effects are being developed, thus making vaccinations more acceptable to the public. Moreover, increased research and development (R&D) investment in the pharmaceutical sector fuels innovation in vaccine development which is facilitating the growth of the market across the globe.

Travel Vaccines Market Report 2023


Who are the key players operating in the industry?

The report covers the major market players including: 

Travel Vaccines Key Players:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abelló A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.

Market Segmentation:

The report has segmented the market into the following categories:

Composition Insights:

  • Mono Vaccines
  • Combination Vaccines

Disease Insights:

  • Hepatitis A 
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Speak to Analyst: https://www.imarcgroup.com/request?type=report&id=1155&flag=C

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com

Popular posts from this blog

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery